clinically insignificant

Related by string. * Clinically : patented clinically proven . demonstrated clinically meaningful . clinically localized prostate . clinically obese . clinically meaningful improvement . clinically meaningful improvements / Insignificant : insignificant speck . militarily insignificant Brig . militarily insignificant . numerically insignificant . statistically insignificant * *

Related by context. Frequent words. (Click for all words.) 67 elevated CRP 66 serum PSA 63 nonmalignant 63 brain lesions 63 serum calcium 63 metabolic acidosis 63 cerebral infarction 62 adenoma 62 colorectal polyps 62 fasting glucose levels 62 cystatin C 62 biochemical recurrence 62 varicocele 62 PSA velocity 62 hematuria 61 oophorectomy 61 hyperbilirubinemia 61 serum uric acid 61 D dimer 60 serum sodium 60 subclinical 60 postoperative complications 60 antigen PSA 60 PCa 60 familial hypercholesterolemia 60 lymph node involvement 60 carotid intima media 60 neurologic symptoms 60 hypoxemia 60 nonsignificant 60 thyroid dysfunction 60 thrombotic events 60 colorectal adenomas 60 neoplastic 60 thromboembolism 60 microvascular complications 60 lung nodules 60 overdiagnosis 60 benign breast 60 de ath 60 malignant lesions 59 alteplase 59 left ventricular dysfunction 59 androgen deprivation 59 confounding variables 59 microalbuminuria 59 Prostate Specific Antigen PSA 59 benign prostate 59 pheochromocytoma 59 albuminuria 59 histologic 59 histopathological 59 coronary artery calcium 59 asymptomatic 59 glomerular filtration rate 59 hippocampal volume 59 mammary tumors 59 atherosclerotic lesions 59 coronary artery calcification 59 aneuploidy 59 renal dysfunction 59 cryptorchidism 59 elevated triglycerides 59 estimated glomerular filtration 59 renal toxicity 59 poorer prognosis 59 systemic toxicity 59 endometrial cancers 59 apolipoprotein B 59 congenital malformations 59 Asymptomatic 59 elevated liver enzymes 58 noncarriers 58 creatinine levels 58 fasting insulin 58 morphologic 58 IGFBP 3 58 cardiotoxicity 58 serum creatinine 58 postmenopausal breast cancer 58 thromboembolic events 58 CMV infection 58 eGFR 58 metabolic abnormalities 58 cardiac dysfunction 58 asthma exacerbations 58 myocardial infarctions 58 estrogen receptor negative 58 carcinoid 58 noncancerous 58 hs CRP 58 myocardial ischemia 58 atypia 58 histologically 58 pre cancerous polyps 58 hypercalcemia 58 hsCRP 58 malignant pleural mesothelioma 58 epithelial ovarian cancer 58 prostate specific 57 prostate specific antigen

Back to home page